Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: 5 - What They Never Told You

Medtronic sees 23 serious medical device recalls in two years

Medtronic, battered by a high number of serious medical device recalls in recent years, says it is toughening its internal assessments for acquiring new products.

Tribune News Service

'The most rewarding and hardest thing I've ever done' - What pregnancy is like when you are type 1 diabetic

Melanie Stephenson-Gray speaks candidly about managing type 1 diabetes as an athlete and a mum

Wales Online

Hollyoaks' Rory Douglas-Speed told he had life-changing condition after rapid weight loss

Diabetes is a major challenge for anyone living with it, but many are confused about the difference between Type 1 and Type 2 diabetes. Hollyoaks star Rory Douglas-Speed was first diagnosed aged eight

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

'Our little girl couldn't stop drinking water - the reason completely changed everything'

Sarah Henderson says her daughter Hollie's diagnosis was a 'shock to the system'

Manchester Evening News

Medtronic to spin off two businesses into standalone company

Medtronic plans to spin off two of its businesses into a separate company, the latest move by the medtech giant to tighten its focus on the areas of high growth.

Tribune News Service

What Are Whales Doing With Medtronic

A whale with a lot of money to spend has taken a noticeably bullish stance on Medtronic. Looking at options history for Medtronic (NYSE:MDT) we detected 10 strange trades.

Benzinga

FDA issues urgent recall on Medtronic surgical tubes

The U.S. Food and Drug Administration has issued a Class I recall, the agency's most serious category, for certain tracheal tubes made by Medtronic.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Check Out What Whales Are Doing With MDT

A whale with a lot of money to spend has taken a noticeably bearish stance on Medtronic. Looking at options history for Medtronic (NYSE:MDT) we detected 17 strange trades.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2022

Benzinga

Medtronic Stock Keeps Ticking Forward

Medical device maker Medtronic (NYSE: MDT) stock is trading down (-14%) for the year. Medtronic is the world's largest medical device maker with a portfolio of glucose monitors, stents, insulin pumps, pacemakers, and catheters. It serves patients in over 150 countries.

Benzinga

Ukrainian refugee, 10, fitted with ‘priceless’ and life-changing insulin pump

Dasha Makarenko urgently needed treatment after she fled Ukraine with her family following the Russian invasion.

The Independent UK

Saudi Arabia, US Sign 18 Agreements in Energy, Other Areas

Saudi Arabia and the United States signed 18 partnership agreements in fields including energy, communications, space and healthcare during a visit by US President Joe Biden. The agreements include deals with US aerospace and defense firms Boeing and Raytheon, as well as healthcare companies Medtronic, Digital Diagnostics, and IQVIA, according…

Asharq Al-Awsat

Medtronic invests in Israel-based company as precursor to acquisition

Medtronic on Tuesday announced a new partnership with CathWorks, establishing the framework for a $585 million acquisition of the digital health company.

Tribune News Service

FDA imposes 'Class 1' recall status on Medtronic's latest HeartWare defect

Federal regulators this week upgraded the recall of Medtronic's HeartWare Ventricular Assist Device to a Class 1 recall, its most serious classification.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

12 Analysts Have This to Say About Medtronic

Within the last quarter, Medtronic (NYSE:MDT) has observed the following analyst ratings:

Benzinga

Check Out What Whales Are Doing With MDT

Someone with a lot of money to spend has taken a bullish stance on Medtronic (NYSE:MDT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

6 Stocks To Buy That Are Near 52-Week Lows

Weakness in the S&P 500 has made life unpleasant for investors so far in 2022, but it has also created buying opportunities in a handful of high-quality stocks. Long-term investors looking to buy the dip can find plenty of stocks to buy that are at or near their lowest prices…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2022

Upgrades

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 27, 2022

Upgrades

Benzinga

Medtronic, DaVita To Jointly Form Kidney Health-Focused Company

Medtronic plc (NYSE:MDT) and DaVita Inc (NYSE:DVA) intend to form a new, independent kidney care-focused medical device company (NewCo). NewCo will focus on developing a broad suite of novel kidney care products and solutions, including future home-based products. Medtronic and DaVita will co-own the NewCo, each with equal equity stakes and led by an…

Benzinga

Why Medtronic Shares Are Plunging Today?

Medtronic Plc's (NYSE:MDT) Q4 FY22 sales of $8.09 billion decreased 1% Y/Y on a reported basis but increased 1% organically, missing the consensus of $8.42 billion. The company has forecasted Q4 organic revenue growth of approximately 5.5%. Q4 adjusted EPS of $1.52 increased 2%, missing the analyst consensus of $1.56. Medtronic's heart device…

Benzinga

Medtronic: Q4 Earnings Insights

Medtronic (NYSE:MDT) reported its Q4 earnings results on Thursday, May 26, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Benzinga

Medtronic's Earnings: A Preview

Medtronic (NYSE:MDT) is set to give its latest quarterly earnings report on Thursday, 2022-05-26. Here's what investors need to know before the announcement. Analysts estimate that Medtronic will report an earnings per share (EPS) of $1.56.

Benzinga

4 Analysts Have This to Say About Medtronic

Within the last quarter, Medtronic (NYSE:MDT) has observed the following analyst ratings:

StockNews.com

2 Wide-Moat Stocks to Add to Your Portfolio Right Now

The major stock market indexes surged yesterday after the Fed Reserve raised benchmark interest rates by half a percentage point. However, the stock market is expected to remain under pressure at least in the near term on continuing macroeconomic and geopolitical concerns. So, we think it could be wise to…

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.